Larinject
Composition for Larinject Products
Larinject Products are primarily used for
Anemia due to chronic kidney disease, Iron deficiency anemiaProducts for Larinject
Larinject-She Injection
vial of 10 ml Injection
MRP₹1973
Larinject Injection
vial of 10 ml Injection
MRP₹2170.31
Larinject 50mg/ml Injection
ampoule of 2 ml Injection
MRP₹508.13
Not Available
Larinject 1000mg Injection
vial of 2 ml Injection
MRP₹420.94
Not Available
Substitute brands for Larinject
About Larinject Products
Uses of Larinject Products
Ferric Carboxymaltose is used in the treatment of anemia due to chronic kidney disease and iron deficiency anemia.
Larinject Products side effects
Common
Side Effects of Larinject are Vomiting, Nausea, Dark colored stool, Headache, Dizziness, High blood pressure, Injection site reactions (pain, swelling, redness).
How Larinject Products work
Ferric Carboxymaltose is an anti-anemic medication. It replenishes the iron stores in your body. Iron is vital for the formation of new red blood cells and hemoglobin, a substance that gives these cells the ability to transport oxygen.
In Depth Information for Larinject Products
- Larinject is used for the treatment of iron deficiency, when oral iron preparations are ineffective or cannot be used.
- Your doctor or nurse will administer it by injection. You will be observed for at least 30 minutes after each injection as it may cause allergic reaction.
- Your blood pressure and blood iron levels will be regularly monitored during treatment with this medication.
- Inform your doctor if you are taking any iron-containing products by mouth.
- Do not consume alcohol when on treatment with this medicine as it may worsen its side effects.
- It may cause your stools to become black or dark in color. This is normal and harmless.
Patient Concerns about Larinject Products
Frequently asked questions about Larinject Products
Q. What precautions are required while administering Larinject-She Injection?
Larinject-She Injection should be administered by staff that is trained in dealing with serious allergic reactions (anaphylactic reaction). Larinject-She Injection can be administered as an undiluted injection, directly into the vein or via a dialyzer if the patient is on dialysis. It can also be diluted with sodium chloride and given as infusion directly into the vein. The patient should be monitored for at least 30 minutes after each injection. Also, the injection should not be given below the skin (subcutaneous route) or in the muscle (intramuscular route).
Q. How should Larinject-She Injection vials be stored before use?
Larinject-She Injection vials should be stored at 20°C to 25°C (68°F to 77°F). Remember, these should not be freezed. The temperature should not deviate more than 15°C to 30°C (59°F to 86°F).
Q. How often can Larinject-She Injection be re-injected?
Usually, two doses of this medicine are given 7 days apart. The hemoglobin is then assessed at least 4 weeks after the final injection to allow time for the RBCs to form. If the reports still show deficiency of iron, it can be re-administered depending on individual need.
Q. Can Larinject-She Injection cause an increase in blood pressure?
Yes, Larinject-She Injection may cause a temporary increase in blood pressure accompanied with facial flushing, dizziness, and nausea. This may occur immediately after you take the medicine and generally disappears within 30 minutes.
Q. What should be done if leakage of Larinject-She Injection occurs?
Incorrect administration of Larinject-She Injection may cause leakage of the medicine at the administration site. The administration must be stopped immediately if there is some leakage. The leakage may cause skin irritation and long-lasting brown discoloration of skin at the administration site.
Q. Is Larinject-She Injection safe in pregnancy?
There is limited data on the use of Larinject-She Injection in pregnancy. It is important to tell your doctor if you are pregnant or are planning to have a baby. Consult your doctor if you become pregnant during treatment with Larinject-She Injection. Your doctor will decide whether you need to continue treatment or discontinue it.
Q. What precautions are required while administering Larinject-She Injection?
Larinject-She Injection should be administered by staff that is trained in dealing with serious allergic reactions (anaphylactic reaction). Larinject-She Injection can be administered as an undiluted injection, directly into the vein or via a dialyzer if the patient is on dialysis. It can also be diluted with sodium chloride and given as infusion directly into the vein. The patient should be monitored for at least 30 minutes after each injection. Also, the injection should not be given below the skin (subcutaneous route) or in the muscle (intramuscular route).
Q. How should Larinject-She Injection vials be stored before use?
Larinject-She Injection vials should be stored at 20°C to 25°C (68°F to 77°F). Remember, these should not be freezed. The temperature should not deviate more than 15°C to 30°C (59°F to 86°F).
Q. How often can Larinject-She Injection be re-injected?
Usually, two doses of this medicine are given 7 days apart. The hemoglobin is then assessed at least 4 weeks after the final injection to allow time for the RBCs to form. If the reports still show deficiency of iron, it can be re-administered depending on individual need.
Q. Can Larinject-She Injection cause an increase in blood pressure?
Yes, Larinject-She Injection may cause a temporary increase in blood pressure accompanied with facial flushing, dizziness, and nausea. This may occur immediately after you take the medicine and generally disappears within 30 minutes.
Q. What should be done if leakage of Larinject-She Injection occurs?
Incorrect administration of Larinject-She Injection may cause leakage of the medicine at the administration site. The administration must be stopped immediately if there is some leakage. The leakage may cause skin irritation and long-lasting brown discoloration of skin at the administration site.
Q. Is Larinject-She Injection safe in pregnancy?
There is limited data on the use of Larinject-She Injection in pregnancy. It is important to tell your doctor if you are pregnant or are planning to have a baby. Consult your doctor if you become pregnant during treatment with Larinject-She Injection. Your doctor will decide whether you need to continue treatment or discontinue it.